LASARTE SAGASTIBELZA; Juan Jose
Patent Applications and Registrations
Patent applications and USPTO patent grants for LASARTE SAGASTIBELZA; Juan Jose.The latest application filed is for "foxp3-binding peptides and uses thereof".
- LASARTE SAGASTIBELZA; Juan Jose - PAMPLONA ES
- LASARTE SAGASTIBELZA; Juan Jose - Navarra ES
- LASARTE SAGASTIBELZA; Juan Jose - Pamplona - Navarra ES
- Lasarte Sagastibelza; Juan Jose - Berriozar ES
| Patent | Date |
|---|---|
| Foxp3-binding Peptides And Uses Thereof App 20200317733 - CASARES LAGAR; Ines Noelia ; et al. | 2020-10-08 |
| FoxP3-binding peptides and uses thereof Grant 10,654,896 - Casares Lagar , et al. | 2020-05-19 |
| Foxp3-binding Peptides And Uses Thereof App 20190276496 - CASARES LAGAR; Ines Noelia ; et al. | 2019-09-12 |
| Agents And Methods Based On The Use Of The Eda Domain Of Fibronectin App 20160215039 - LECLERC; Claude ; et al. | 2016-07-28 |
| Agents and methods based on the use of the EDA domain of fibronectin Grant 9,155,783 - Leclerc , et al. October 13, 2 | 2015-10-13 |
| Immuno-stimulant Combination For Prophylaxis And Treatment Of Hepatitis C App 20140056943 - ZABALETA AZPIROZ; Aintzane ; et al. | 2014-02-27 |
| Peptides with capacity to bind to scurfin and applications Grant 8,524,860 - Casares Lagar , et al. September 3, 2 | 2013-09-03 |
| Peptides With The Capacity To Bind To Interleukin-10 (il-10) App 20130064790 - MANTEROLA CAREAGA; Lorea ; et al. | 2013-03-14 |
| Therapeutic Compositions For The Treatment of HPV-Induced Diseases App 20120237535 - Berraondo-Lopez; Pedro ; et al. | 2012-09-20 |
| Peptides with capacity for binding with interleukine 10 (IL-10) Grant 8,148,334 - Manterola Careaga , et al. April 3, 2 | 2012-04-03 |
| Use Of Phenol-soluble Modulins For Vaccine Development App 20110268757 - Borras Cuesta; Francisco ; et al. | 2011-11-03 |
| Peptides With Capacity To Bind To Scurfin And Applications App 20100267623 - Casares Lagar; Ines Noelia ; et al. | 2010-10-21 |
| PEPTIDES WITH THE CAPACITY TO BIND TO TRANSFORMING GROWTH FACTOR beta 1 (TGF-beta 1) App 20100222280 - DOTOR HERRER AS; JAVIER ; et al. | 2010-09-02 |
| Peptides With Capacity For Binding With Interleukine 10 (il-10) App 20100168015 - Manterola Careaga; Lorea ; et al. | 2010-07-01 |
| Use of cardiotrophin in liver diseases Grant 7,732,397 - Bustos De Abajo , et al. June 8, 2 | 2010-06-08 |
| Immuno-Stimulant Combination for Prophylaxis and Treatment of Hepatitis C App 20100047231 - Zabaleta Azpiroz; Aintzane ; et al. | 2010-02-25 |
| Peptides with the capacity to bind to transforming growth factor .beta.1 (TGF-.beta.1) Grant 7,666,841 - Dotor De Las Herrerias , et al. February 23, 2 | 2010-02-23 |
| Use Of Tgf-b1 Inhibitor Peptides In The Preparation Of An Immune Response Modulating Agent App 20090263410 - Borras Cuesta; Francisco ; et al. | 2009-10-22 |
| Agents and methods based on the use of the eda domian of fibronectin App 20090220532 - Leclerc; Claude ; et al. | 2009-09-03 |
| Novel T-Helper Antigenic Determinant (THD) Peptides App 20090220533 - Borras Cuesta; Francisco ; et al. | 2009-09-03 |
| TGF.beta.1-inhibitor peptides Grant 7,528,226 - Ezquerro Saenz , et al. May 5, 2 | 2009-05-05 |
| TGFbeta1-inhibitor peptides App 20070014767 - Ezquerro Saenz; Ignacio Jose ; et al. | 2007-01-18 |
| TGF.beta.1 inhibitor peptides Grant 7,057,013 - Ezquerro Saenz , et al. June 6, 2 | 2006-06-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 